Physician

Adam Lavell Kemp, M.D.

According to 2025 Medicare claims, Adam Kemp, M.D. (NPI: 1811342967) practices interventional pain management (ipm) in the Eugene-Springfield, OR market, with the plurality of this provider's patient population coming from Lane, OR. This provider's primary affiliated billing organization is OREGON PAIN & SPINE SPECIALISTS PC (NPI: 1760227888; TIN: 993082728) and primary practice location at 97401-8187.

Kemp's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 240 traditional Medicare patients, billed 3,051 HCPCS/CPT codes, and received $124,325 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 682 prescription claims across 207 beneficiaries totaling $24,726 in drug costs, led by Oxycontin (Oxycodone Hcl). Open Payments data shows 57 records totaling $3,481. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $897 to $24,726. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$90K$180K2021 Medicare payment: $38,810 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $149,917 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $179,873 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $124,325 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202189404$38,810
20221542,756$149,917
20231952,645$179,873
20242403,051$124,325

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$21K$42K2017 Drug cost: $897 (USD; Tot_Drug_Cst)2020 Drug cost: $8,328 (USD; Tot_Drug_Cst)2021 Drug cost: $41,598 (USD; Tot_Drug_Cst)2022 Drug cost: $26,813 (USD; Tot_Drug_Cst)2023 Drug cost: $30,449 (USD; Tot_Drug_Cst)2024 Drug cost: $24,726 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R15$897
2018N/RN/RN/R
2019N/RN/RN/R
202045143$8,328
2021136551$41,598
2022170737$26,813
2023184813$30,449
2024207682$24,726

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more9797$109
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more88122$94
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more103160$65
J3301Injection, triamcinolone acetonide, not otherwise specified, 10 mg90681$1
J1100Injection, dexamethasone sodium phosphate, 1 mg561,047$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
OxycontinOxycodone Hcl15399$4,017
BuprenorphineBuprenorphine12324$3,060
Buprenorphine HclBuprenorphine Hcl32898$2,414
Oxycodone HclOxycodone Hcl922,268$1,989
CelecoxibCelecoxib451,876$1,876

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.57$3,481Boston Scientific Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Lavell Kemp, M.D.?

Tedicare shows public-source Medicare data for Adam Lavell Kemp, M.D. (NPI 1811342967), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Lavell Kemp, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam Lavell Kemp, M.D.?

Adam Lavell Kemp, M.D. is linked to OREGON PAIN & SPINE SPECIALISTS PC (billing NPI 1760227888) in the available physician profile data.

Does Adam Lavell Kemp, M.D. have Open Payments data?

Adam Lavell Kemp, M.D. has 57 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.